Aspirin and PIK3CA Mutations in Colorectal Cancer

被引：0
|
作者：
Kirstein, M. M. [1 ]
Vogel, A. [1 ]
机构：
[1] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30625 Hannover, Germany
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2014年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [41] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
  • [42] Characterization of PIK3CA mutations in lobular breast cancer
    Desmedt, C.
    Metzger
    Fumagalli, D.
    Brown, D.
    Singhal, S.
    Vincent, D.
    Adnet, P-Y
    Smeets, D.
    Berthed, F.
    Galant, C.
    Salgado, R.
    Veys, I.
    Saini, K.
    Pruneri, G.
    Krop, I.
    Winer, E.
    Michiels, S.
    Piccart, M.
    Lambrechts, D.
    Larsimont, D.
    Viale, G.
    Sotiriou, C.
    CANCER RESEARCH, 2012, 72
  • [43] PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
    Qiang Wang
    Yan-long Shi
    Kai Zhou
    Li-li Wang
    Ze-xuan Yan
    Yu-lin Liu
    Li-li Xu
    Shi-wei Zhao
    Hui-li Chu
    Ting-ting Shi
    Qing-hua Ma
    Jingwang Bi
    Cell Death & Disease, 9
  • [44] Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations
    Yasin, Faiza
    Sokol, Ethan
    Vasan, Neil
    Pavlick, Dean C.
    Huang, Richard S. P.
    Pelletier, Maureen
    Levy, Mia Alyce
    Pusztai, Lajos
    Lacy, Jill
    Zhang, Janie Yue
    Ross, Jeffrey S.
    Cecchini, Michael
    ONCOLOGIST, 2024, 29 (12): : 1059 - 1067
  • [45] PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
    Wang, Qiang
    Shi, Yan-long
    Zhou, Kai
    Wang, Li-li
    Yan, Ze-xuan
    Liu, Yu-lin
    Xu, Li-li
    Zhao, Shi-wei
    chu, Hui-li
    Shi, Ting-ting
    Mai, Qing-hua
    Bi, Jingwang
    CELL DEATH & DISEASE, 2018, 9
  • [46] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    ONCOTARGET, 2017, 8 (14) : 22305 - 22306
  • [47] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Zhu, Yu-Fen
    Yu, Bao-Hua
    Li, Da-Li
    Ke, Hong-Lin
    Guo, Xian-Zhi
    Xiao, Xiu-Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (28) : 3745 - 3751
  • [48] Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
    Foltran, Luisa
    De Maglio, Giovanna
    Pella, Nicoletta
    Ermacora, Paola
    Aprile, Giuseppe
    Masiero, Elena
    Giovannoni, Mariella
    Iaiza, Emiliana
    Cardellino, Giovanni Gerardo
    Lutrino, Stefania Eufemia
    Mazzer, Micol
    Giangreco, Manuela
    Pisa, Federica Edith
    Pizzolitto, Stefano
    Fasola, Gianpiero
    FUTURE ONCOLOGY, 2015, 11 (04) : 629 - 640
  • [49] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Yu-Fen Zhu
    World Journal of Gastroenterology, 2012, (28) : 3745 - 3751
  • [50] KRAS, BRAF, PIK3CA MUTATIONS AND PTEN EXPRESSION IN HUMAN COLORECTAL CANCER - RELATIONSHIP WITH METASTATIC COLORECTAL CANCER
    Wang, X.
    Li, H.
    Lu, Y.
    Zhao, Q.
    ANNALS OF ONCOLOGY, 2010, 21 : 64 - 64
12345